Clinicn Investigator, Full Prf Cancer Center, Mass General Research Institute

Giovanni Armenise - Harvard Professor of Neurology Harvard Medical School

Neurologist Neurology, Massachusetts General Hospital

MD Tulane University School of Medicine 1998

PhD 1998

central nervous system neoplasms; neurilemmoma; neurofibromatoses; neurofibromatosis 1; neurofibromatosis 2; neuroma, acoustic; peripheral nervous system neoplasms; quinazolines

Scott Plotkin, MD, PhD, is Giovanni Armenise Professor of Neurology at Harvard Medical School and is the Executive Director of Stephen E. and Catherine Pappas Center for Neuro-Oncology at Massachusetts General Hospital.  Dr. Plotkin’s research is focused on designing clinical trials for persons with genetic tumor syndromes such as neurofibromatosis (NF) and schwannomatosis (SWN).  He is particularly interested in novel trial designs for rare diseases and in new approaches to gene therapy.   He has served as principal investigator on single and multi-center clinical trials and is an active member of several national consortia.  In 2011, he co-founded the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.  This collaboration has published consensus recommendations for clinical trial endpoints in trials for NF and SWN patients and continues to work closely with the Food and Drug Administration, European Medicines Agency, and other agencies.  He is the principal investigator on multiple federal grants that support a range of projects from running clinical trials to training physician scientists to advancing health care for patients.